Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs. Many of these individuals are complic...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-07-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/13/7/155 |
| _version_ | 1797562027236917248 |
|---|---|
| author | Yufeng Wei Rameen Shah |
| author_facet | Yufeng Wei Rameen Shah |
| author_sort | Yufeng Wei |
| collection | DOAJ |
| description | As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs. Many of these individuals are complicated by underlying health conditions, such as cardiovascular and lung diseases and undermined immune systems. During the pandemic, access to the healthcare systems and support groups is greatly diminished. Current research on COVID-19 has not addressed the unique challenges facing individuals with SUDs, including the heightened vulnerability and susceptibility to the disease. In this systematic review, we will discuss the pathogenesis and pathology of COVID-19, and highlight potential risk factors and complications to these individuals. We will also provide insights and considerations for COVID-19 treatment and prevention in patients with SUDs. |
| first_indexed | 2024-03-10T18:22:50Z |
| format | Article |
| id | doaj.art-85ee9ec905084ae599af41bcf6d1e17d |
| institution | Directory Open Access Journal |
| issn | 1424-8247 |
| language | English |
| last_indexed | 2024-03-10T18:22:50Z |
| publishDate | 2020-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj.art-85ee9ec905084ae599af41bcf6d1e17d2023-11-20T07:13:38ZengMDPI AGPharmaceuticals1424-82472020-07-0113715510.3390/ph13070155Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and ComplicationsYufeng Wei0Rameen Shah1Department of Chemistry, New Jersey City University, Jersey City, NJ 07305, USADepartment of Chemistry, New Jersey City University, Jersey City, NJ 07305, USAAs the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs. Many of these individuals are complicated by underlying health conditions, such as cardiovascular and lung diseases and undermined immune systems. During the pandemic, access to the healthcare systems and support groups is greatly diminished. Current research on COVID-19 has not addressed the unique challenges facing individuals with SUDs, including the heightened vulnerability and susceptibility to the disease. In this systematic review, we will discuss the pathogenesis and pathology of COVID-19, and highlight potential risk factors and complications to these individuals. We will also provide insights and considerations for COVID-19 treatment and prevention in patients with SUDs.https://www.mdpi.com/1424-8247/13/7/155COVID-19SARS-CoV-2coronavirussubstance use disorder (SUD)immunologyneuroinflammation |
| spellingShingle | Yufeng Wei Rameen Shah Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications Pharmaceuticals COVID-19 SARS-CoV-2 coronavirus substance use disorder (SUD) immunology neuroinflammation |
| title | Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
| title_full | Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
| title_fullStr | Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
| title_full_unstemmed | Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
| title_short | Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications |
| title_sort | substance use disorder in the covid 19 pandemic a systematic review of vulnerabilities and complications |
| topic | COVID-19 SARS-CoV-2 coronavirus substance use disorder (SUD) immunology neuroinflammation |
| url | https://www.mdpi.com/1424-8247/13/7/155 |
| work_keys_str_mv | AT yufengwei substanceusedisorderinthecovid19pandemicasystematicreviewofvulnerabilitiesandcomplications AT rameenshah substanceusedisorderinthecovid19pandemicasystematicreviewofvulnerabilitiesandcomplications |